It is likely that both psychological aspects of breast cancer diagnosis (e.g. anxiety [17]) as well as the hormonal effects of treatment (e.g. side-effects from prescribed medications such as selective oestrogen receptor modifiers (SERMs) and aromatase inhibitors (AIs)) [18]) contribute to the sleep disruption experienced by breast cancer patients. This evidence concerns the gene CYP19A1 and breast cancer.